186 related articles for article (PubMed ID: 29121080)
1. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
[TBL] [Abstract][Full Text] [Related]
2. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.
Luangrath MA; Schmidt ME; Hartwig SM; Varga SM
Immunohorizons; 2021 Feb; 5(2):59-69. PubMed ID: 33536235
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection.
Schmidt ME; Meyerholz DK; Varga SM
Mucosal Immunol; 2020 May; 13(3):507-517. PubMed ID: 31844172
[TBL] [Abstract][Full Text] [Related]
5. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
6. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
7. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
8. Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus.
Hu B; Jiang J; Zhan J; Li G; Jiang Y; Guan X; Chen Y; Fang Z
Virol J; 2014 Aug; 11():142. PubMed ID: 25107552
[TBL] [Abstract][Full Text] [Related]
9. Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein.
Cherukuri A; Patton K; Gasser RA; Zuo F; Woo J; Esser MT; Tang RS
Clin Vaccine Immunol; 2013 Feb; 20(2):239-47. PubMed ID: 23239796
[TBL] [Abstract][Full Text] [Related]
10. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
Johnson JE; McNeil LK; Megati S; Witko SE; Roopchand VS; Obregon JH; Illenberger DM; Kotash CS; Nowak RM; Braunstein E; Yurgelonis I; Jansen KU; Kalyan NK; Sidhu MK
Immunol Lett; 2013 Feb; 150(1-2):134-44. PubMed ID: 23261719
[TBL] [Abstract][Full Text] [Related]
11. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
[TBL] [Abstract][Full Text] [Related]
12. Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.
Habibi MS; Jozwik A; Makris S; Dunning J; Paras A; DeVincenzo JP; de Haan CA; Wrammert J; Openshaw PJ; Chiu C;
Am J Respir Crit Care Med; 2015 May; 191(9):1040-9. PubMed ID: 25730467
[TBL] [Abstract][Full Text] [Related]
13. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.
Varese A; Nakawesi J; Farias A; Kirsebom FCM; Paulsen M; Nuriev R; Johansson C
PLoS Pathog; 2022 Feb; 18(2):e1010272. PubMed ID: 35108347
[TBL] [Abstract][Full Text] [Related]
14. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
Olson MR; Hartwig SM; Varga SM
J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
[TBL] [Abstract][Full Text] [Related]
15. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
Front Immunol; 2020; 11():1673. PubMed ID: 32849580
[TBL] [Abstract][Full Text] [Related]
16. Determining the breadth of the respiratory syncytial virus-specific T cell response.
McDermott DS; Knudson CJ; Varga SM
J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
[TBL] [Abstract][Full Text] [Related]
17. Airway T cells protect against RSV infection in the absence of antibody.
Kinnear E; Lambert L; McDonald JU; Cheeseman HM; Caproni LJ; Tregoning JS
Mucosal Immunol; 2018 Jan; 11(1):249-256. PubMed ID: 28537249
[TBL] [Abstract][Full Text] [Related]
18. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
19. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Green CA; Sande CJ; Scarselli E; Capone S; Vitelli A; Nicosia A; Silva-Reyes L; Thompson AJ; de Lara CM; Taylor KS; Haworth K; Hutchings CL; Cargill T; Angus B; Klenerman P; Pollard AJ
J Infect; 2019 May; 78(5):382-392. PubMed ID: 30742894
[TBL] [Abstract][Full Text] [Related]
20. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]